Picture of Alterity Therapeutics logo

ATHE — Alterity Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Brief: Alterity Therapeutics Granted US FDA Fast Track Designation For Lead Candidate To Treat Multiple System Atrophy

May 5 (Reuters) - Alterity Therapeutics Ltd ATH.AX:

ALTERITY THERAPEUTICS GRANTED U.S. FDA FAST TRACK DESIGNATION FOR ATH434 TO TREAT MULTIPLE SYSTEM ATROPHY

Source text: ID:nGNX20Qrv1

Further company coverage: ATH.AX

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Alterity Therapeutics

See all news